PRECISION IN GLOBAL
REGULATORY STRATEGY
With more than 35 years of specialized expertise, we partner with medical device, IVD, and combination product innovators to navigate global compliance through pragmatic, high-quality, and sustainable solutions.
OUR HERITAGE
EST.
1991
For over three decades, J. Michener Whipple & Partners LLC has been defined by a singular commitment: providing the medical device and diagnostics industries with the highest level of regulatory precision. Founded in 1991, our firm emerged from a vision to transform compliance from a mandatory hurdle into a strategic pillar for innovation and market success.
Our story is one of continuous evolution, paralleling the rapid advancements in medical technology and the ever-shifting global regulatory landscape. We have grown from a specialized boutique advisory into a trusted global consultancy, having guided hundreds of products through the complexities of FDA, EU MDR/IVDR, and international health authority requirements.
Today, we remain anchored by our founding principles of integrity, technical mastery, and pragmatic problem-solving. We don't just provide advice; we partner with your team to build sustainable, risk-based quality systems that protect patients and ensure your life-saving technologies reach those who need them most.
Our Domain Expertise
Regulatory Strategy & Submissions
Navigating global frameworks for high-risk medical devices, IVDs, and combination products with precision-engineered submission strategies for FDA, EU MDR/IVDR, and beyond.
QMS Design & Implementation
Architecting robust, scalable ISO 13485:2016 and FDA 21 CFR Part 820 compliant quality systems that balance regulatory rigor with operational efficiency and sustainability.
Clinical Evidence & CER
Scientific assessment of clinical data, state-of-the-art literature reviews, and creation of Clinical Evaluation Reports (CER) and Performance Evaluation Reports (PER) for complex diagnostic tools.
Audit & Readiness Consulting
Securing market access through expert MDSAP and health authority inspection readiness. We provide deep-dive gap analysis, corrective action strategies, and hands-on remediation support.
Our Expert Advisory Team
James Whipple, M.S.
Dr. Eleanor Vance
Marcus Thorne, RAC
Director of Quality Systems | Certified ISO 13485 Lead Auditor specializing in MDR/IVDR compliance and remediation.
Founder & Principal Consultant | Global Regulatory Strategy Specialist with 35+ years of industry leadership.
Senior Regulatory Associate | Expert in FDA 510(k) submissions, technical file development, and clinical evaluation reports.
GUIDING PRINCIPLES
- Integrity: Unwavering commitment to honesty and transparency in all regulatory and health authority interactions.
- Excellence: Delivering precision-driven consulting solutions that meet the highest global quality standards.
- Innovation: Adaptive strategies that enable cutting-edge medical technologies to navigate complex compliance landscapes.
- Accountability: Ensuring every quality management system we design is robust, compliant, and ready for inspection.
- Partnership: Building collaborative relationships that align with our clients' long-term commercial and safety goals.
Why Partner With J Michener Whipple & Partners
Regulatory Technical Depth
Pragmatic Integrated Solutions
Proven Global Success
We bring over 35 years of specialized experience in global regulatory frameworks, ensuring your MedTech and IVD innovations meet even the most complex international standards.
From securing FDA clearance to navigating EU MDR certification, we have a clear history of achieving critical milestones for disruptive medical technologies.
Our approach bridges the gap between quality management, risk, and operations. We deliver business-aligned systems that are both sustainable and cost-effective.
Ready to Ensure Quality Compliance?
Partner with J. Michener Whipple & Partners to navigate the complexities of global regulatory frameworks and achieve sustainable market success through expert advisory solutions.